TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2009

Phase II study of flavopiridol in relapsed chronic lymphocytic leukemia demonstrating high response rates in genetically high-risk disease.

Thomas S Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.